What are the most common side effects of IOHEXOL?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for IOHEXOL. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is IOHEXOL the same as Omnipaque?

Omnipaque is a brand name for IOHEXOL. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

IOHEXOL

Q: What is IOHEXOL used for?

IOHEXOL (brand name Omnipaque) is a Diagnostic Agent indicated for 1 INDICATIONS AND USAGE OMNIPAQUE is a radiographic contrast agent indicated for intrathecal, intra-arterial, intravenous.

Q: How does IOHEXOL work?

IOHEXOL works through the following mechanism: 12.1 Mechanism of Action The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohexol provides time-dependent image contrast which may assist in visualizing body structures..

Diagnostic Agent

Brand names: Omnipaque

Intravenous

Mechanism of Action

12.1 Mechanism of Action The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohexol provides time-dependent image contrast which may assist in visualizing body structures.

Indications

1 INDICATIONS AND USAGE OMNIPAQUE is a radiographic contrast agent indicated for intrathecal

intra-arterial

intravenous

oral

rectal

intraarticular

Contraindications

• 4 CONTRAINDICATIONS OMNIPAQUE for hysterosalpingography is contraindicated during pregnancy or suspected pregnancy
• menstruation or when menstruation is imminent
• within 6 months after termination of pregnancy
• within 30 days after conization or curettage
• when signs of infection are present in any portion of the genital tract including the external genitalia

FDA Warnings

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Life-threatening or fatal reactions can occur
Minimize dose and maintain adequate hydration to minimize risk
5 ) Thyroid Dysfunction in Pediatric Patients 0 to 3 Years of Age: Individualize thyroid function monitoring based on risk factors such as prematurity
1 Risks Associated with Intrathecal Administration of OMNIPAQUE Injection 140 mg Iodine/mL and 350 mg Iodine/mL Use only the iodine concentrations and presentations recommended for intrathecal procedures [see Dosage and Administration (2

Known Side Effects

8 documented side effects by frequency

Itching

>10%

Shortness of Breath

>10%

Nausea

1-10%

Vomiting

1-10%

Rash

1-10%

Cough

0.1-1%

Low Blood Pressure

0.1-1%

Fever

0.1-1%

Community Discussions

No community discussions found for IOHEXOL yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → IOHEXOL openFDA label JSON → IOHEXOL FAERS adverse-event reports → IOHEXOL ClinicalTrials.gov → completed Phase 2+ trials of IOHEXOL

Compare With

11 available comparisons

Formulations

Dosage Forms

Tablet

Route

Intravenous